1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2The Lung Cancer Precision Medicine Center of Excellence, Johns Hopkins University ...
1Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
PARP inhibitor sensitivity is associated with cGAS–STING–IFN signaling, which can be harnessed by combining PARP inhibitors with STING agonists to overcome acquired resistance and requires NK cells to ...
The combination of anti-TROP2 ADCs with PD-(L)1 inhibitors represents a promising therapeutic strategy, merging targeted therapy with immunotherapy to improve treatment outcomes. Clinical trials are ...
Bristol Meyers Squib, Seattle, WA.
Abstract. Molecular glue degrader (MGD) is an emerging therapeutic strategy offering an exciting alternative to traditional small molecules exploring new target space. These small molecules interact ...
BIK Therapeutics Inc., Seongnam, Republic of Korea.
Search for other works by this author on: ...
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Washington University In St. Louis, St. Louis, MO.
Affinity Biopharmaceutical Co., Ltd., Shanghai, China.
University of Miami Miller School of Medicine, Miami, FL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results